XML 45 R34.htm IDEA: XBRL DOCUMENT
v3.21.2

Earnings per Share (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2021
Earnings Per Share [Abstract] |
Components of basic and diluted earnings per share | The following table sets forth the components of basic and diluted EPS ($ in thousands, except per share):
| Three months ended June 30, 2021 |  | Three months ended June 30, 2020
| Income (Numerator) |  | Shares (Denominator) |  | Per Share Amount |  | Income (Numerator) |  | Shares (Denominator) |  | Per Share Amount
Basic EPS |  |  |  |  |  |  |  |  |  |  |
Consolidated net income attributable to common stockholders | $ | 10,378 |  |  | 22,825,804 |  |  |  |  | $ | 6,242 |  |  | 22,808,943 |  |  |
Allocation of earnings to participating restricted shares | (78) |  |  | — |  |  |  |  | (33) |  |  | — |  |  |
Consolidated net income attributable to unrestricted common stockholders | $ | 10,300 |  |  | 22,825,804 |  |  | $ | 0.45 |  |  | $ | 6,209 |  |  | 22,808,943 |  |  | $ | 0.27 |
Effect of dilutive securities(1) |  |  |  |  |  |  |  |  |  |  |
Restricted stock grants and Manager and director fee shares(2) | — |  |  | — |  |  |  |  | 33 |  |  | 120,906 |  |  |
Interest expense (add back) and assumed conversion of shares from convertible senior notes(3) | 2,255 |  |  | 7,372,892 |  |  |  |  | — |  |  | — |  |  |
Diluted EPS |  |  |  |  |  |  |  |  |  |  |
Consolidated net income attributable to common stockholders and dilutive securities | $ | 12,555 |  |  | 30,198,696 |  |  | $ | 0.42 |  |  | $ | 6,242 |  |  | 22,929,849 |  |  | $ | 0.27 |
(1)The Company's outstanding warrants for an addition 6,500,000 shares of common stock and effect of the put option share settlement would have an anti-dilutive effect on diluted earnings per share for the three months ended June 30, 2021 and June 30, 2020, and have not been included in the calculation. (2)The effect of restricted stock grants and manager and director fee shares on the Company's diluted EPS calculation for the three months ended June 30, 2021 would have been anti-dilutive and has been removed from the calculation. (3)The effect of interest expense and assumed conversion of shares from convertible notes on the Company's diluted EPS calculation for the three months ended June 30, 2020 would have been anti-dilutive and has been removed from the calculation.
| Six months ended June 30, 2021 |  | Six months ended June 30, 2020
| Income (Numerator) |  | Shares (Denominator) |  | Per Share Amount |  | Income (Numerator) |  | Shares (Denominator) |  | Per Share Amount
Basic EPS |  |  |  |  |  |  |  |  |  |  |
Consolidated net income attributable to common stockholders | $ | 17,382 |  |  | 22,821,416 |  |  |  | $ | 6,642 |  |  | 22,439,648 |  |
Allocation of earnings to participating restricted shares | (130) |  |  | — |  |  |  | (35) |  |  | — |  |
Consolidated net income attributable to unrestricted common stockholders | $ | 17,252 |  |  | 22,821,416 |  | $ | 0.76 |  |  | $ | 6,607 |  |  | 22,439,648 |  | $ | 0.29 |
Effect of dilutive securities(1) |  |  |  |  |  |  |  |  |  |  |
Restricted stock grants and Manager and director fee shares(2) | — |  |  | — |  |  |  | 35 |  |  | 120,268 |  |
Interest expense (add back) and assumed conversion of shares from convertible senior notes(3) | 4,599 |  |  | 7,520,222 |  |  |  | — |  |  | — |  |  |
Diluted EPS |  |  |  |  |  |  |  |  |  |  |
Consolidated net income attributable to common stockholders and dilutive securities | $ | 21,851 |  |  | 30,341,638 |  | $ | 0.72 |  |  | $ | 6,642 |  |  | 22,559,916 |  | $ | 0.29 |
(1)The Company's outstanding warrants for an addition 6,500,000 shares of common stock and effect of the put option share settlement would have an anti-dilutive effect on diluted earnings per share for the six months ended June 30, 2021 and June 30, 2020, and have not been included in the calculation. (2)The effect of restricted stock grants and manager and director fee shares on the Company's diluted EPS calculation for the six months ended June 30, 2021 would have been anti-dilutive and has been removed from the calculation. (3)The effect of interest expense and assumed conversion of shares from convertible notes on the Company's diluted EPS calculation for the six months ended June 30, 2020 would have been anti-dilutive and has been removed from the calculation.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257 + Details
Name: | us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration